BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » Company news
Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours

Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours

Posted in: Company news, Research group news|November 18, 2019

Newly published article in Scientific Reports (www.nature.com/scientificreports) about the development of a novel platform for intravital 3D imaging of RT2 tumours to facilitate real-time studies of cancer progression. Full access to article is found HERE.

Read more »
Per-Olof Berggren has been elected to The National Academy of Medicine

Per-Olof Berggren has been elected to The National Academy of Medicine

Posted in: Company news|October 17, 2016

Per-Olof Berggren has been elected to The National Academy of Medicine The National Academy of Medicine announced today the election of 70 U.S. members and 9 international members during its annual meeting. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have …

Read more »
Professor Berggren’s distinctions 2012

Professor Berggren’s distinctions 2012

Posted in: Company news, Society|January 3, 2013

Professor Per-Olof Berggren has received 4 major distinctions during 2012:  Alex Hirsch from Karolinska Institutet, Wallenberg Scholars, The Novo Nordisk Foundation Advanced Grant and Kroc Lecture at Boston University Medical Center. Professor Berggren’s distinctions are for the following achievements: Axel Hirsch Prize from Karolinska Institutet. The prize is for scientific achievements, which are potentially of major significance to the treatment of …

Read more »
Biocrine featured in NyTeknik

Biocrine featured in NyTeknik

Posted in: Company news, Society|November 14, 2012

Biocrine’s CEO Professor PO Berggren was interviewed by NyTeknik, Swedish leading technology and IT newspaper. Treating diabetes with transplanted insulin-producing islets of Langerhans was the main subject of the discussion. Transplantation into the eye is a novel method developed by Prof Berggren’s research group. So far, the procedure has been thoroughly tested in mice leading …

Read more »
Biocrine’s home page launched

Biocrine’s home page launched

Posted in: Company news|February 21, 2012

www.biocrine.se is live Our company web site www.biocrine.com is now launched. We will be looking forward to your feedback on info@biocrine.se. With best regards, The Biocrine team

Read more »
Biocrine’s CEO featured at IVA’s annual meeting

Biocrine’s CEO featured at IVA’s annual meeting

Posted in: Company news, Society|February 21, 2012

        On the 28th of October 2011, Biocrine was featured as one of the prominent life science companies on the 92nd annual meeting of IVA. In an interview for IVA, Biocrine’s CEO Per-Olof Berggren talked about the main focus of the research; understanding of how a healthy insulin producing beta cell works, …

Read more »

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications May 29, 2023
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022
  • Kallelse till årsstämma 22 juni 2021
    Kallelse till årsstämma 22 juni 2021 May 19, 2021
  • Metabolic derangements caused by a high-fat diet may be possible to eliminate
    Metabolic derangements caused by a high-fat diet may be possible to eliminate March 15, 2021
  • Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye
    Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye November 28, 2019
  • Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours
    Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours November 18, 2019
  • Novel findings explain indirect regulation of glucose homeostasis
    Novel findings explain indirect regulation of glucose homeostasis August 21, 2019
  • Transplanted cells reveal early signs of type 1 diabetes
    Transplanted cells reveal early signs of type 1 diabetes May 15, 2019

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved